Bank of New York Mellon’s Intermolecular, Inc. IMI Stock Holding History

Bank of New York Mellon’s Portfolio IMI Stock Details IMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,597	Closed	-$15K	–	4451
2017 Q4	$15K	Buy	+10,597	New	+$12.8K	﹤0.01%	4315
2016 Q3	–	Sell	-11,795	Closed	-$17K	–	4338
2016 Q2	$17K	Hold	11,795	–	–	﹤0.01%	4277
2016 Q1	$30K	Hold	11,795	–	–	﹤0.01%	4142
2015 Q4	$27K	Hold	11,795	–	–	﹤0.01%	4253
2015 Q3	$22K	Hold	11,795	–	–	﹤0.01%	4316
2015 Q2	$23K	Buy	+11,795	New	+$21.8K	﹤0.01%	4214
2014 Q2	–	Sell	-58,553	Closed	-$164K	–	4289
2014 Q1	$164K	Sell	58,553 -437	-0.7%	-$1.59K	﹤0.01%	3897
2013 Q4	$290K	Buy	58,990 +2,489	+4%	+$14.1K	﹤0.01%	3751
2013 Q3	$312K	Buy	56,501 +6,774	+14%	+$42.6K	﹤0.01%	3667
2013 Q2	$361K	Buy	+49,727	New	+$423K	﹤0.01%	3611

Other funds holding IMI

RCM

Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

SPM

Symmetry Peak Management Radnor, Pennsylvania $359M AUM 146.87% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Horizon Kinetics New York $3.06B AUM 5.37% 1-Year Est. Return

Bank of New York Mellon's IMI Position: Q1 2018 in Review

Bank of New York Mellon sold out of Intermolecular, Inc. (IMI) in Q1 2018, closing a stake of 10,597 shares — an estimated $15K sold.

Bank of New York Mellon first reported a position in IMI in Q2 2013 and held it in 10 quarters. The position peaked at $361K in Q2 2013. 26 funds tracked by Wall St. Rank hold IMI as of Q1 2018.

Bank of New York Mellon reported no remaining Intermolecular, Inc. position as of Q1 2018 after selling out during the quarter.
Bank of New York Mellon sold 10,597 Intermolecular, Inc. shares in Q1 2018, an estimated $15K.
Bank of New York Mellon first reported a position in Intermolecular, Inc. in Q2 2013 and held it in 10 quarters.
Bank of New York Mellon's Intermolecular, Inc. position peaked at $361K in Q2 2013.
26 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q1 2018.

Based on Bank of New York Mellon's 13F filing for Q1 2018, filed 15 May 2018.